Trevi Therapeutics is headquartered at 195 Church Street, 16th Floor, New Haven, CT 06510. The corporate office phone number is 203-304-2499. Trevi Therapeutics was founded in 2011, and the company is incorporated in Delaware. Trevi Therapeutics common stock began trading on the Nasdaq Global Market on May 7, 2019, listed under the symbol “TRVI”. To find out more about Trevi Therapeutics visit our webpage at www.trevitherapeutics.com.
Click here to get the latest corporate news releases.
Click here to view financial reports, the annual report and proxy.
Click here to find the contact for investor inquiries.
Click here to access the documents Trevi Therapeutics has filed with the Securities and Exchange Commission (SEC), including Forms 10-K and 10-Q.
Click here to sign up to receive Company press releases and information.
Trevi’s transfer agent and registrar for the common stock of Trevi Therapeutics, Inc is Computershare Trust Company, N.A.
Regular Delivery:
Computershare
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
Computershare
150 Royall St., Suite 101
Canton, MA 02021
For questions about your stock:
Please contact our transfer agent, Computershare Trust Company, N.A.
Online - Computershare Investor Services, Computershare Contact
Phone – (877) 373-6374 (US, Canada, Puerto Rico); (781) 575-3100 (non-US)
Email – web.queries@computershare.com
To change the address on your shareholder account:
Send both your old and new addresses to our transfer agent, Computershare, 150 Royall St., Suite 101, Canton, MA 02021.
To replace a lost stock certificate:
Contact our transfer agent, Computershare Trust Company, N.A. The transfer agent can look up your records and make any necessary adjustments.
The auditor for Trevi Therapeutics is Ernst & Young LLP. Trevi Therapeutics’ fiscal year-end is December 31st. Trevi Therapeutics does not have a direct stock purchase plan. Click here for more details on the Executive Management team and Board of Directors.